Tam VH - Search Results

1

Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria.

Tam VH, Abodakpi H, Wang W, Ledesma KR, Merlau PR, Chan K, Altman R, Tran TT, Nikolaou M, Sofjan AK. Tam VH, et al. J Antimicrob Chemother. 2021 Jan 1;76(1):179-183. doi: 10.1093/jac/dkaa412. J Antimicrob Chemother. 2021. PMID: 33035321 Free PMC article.

2

Pharmacodynamics of cefepime in patients with Gram-negative infections.

Tam VH, McKinnon PS, Akins RL, Rybak MJ, Drusano GL. Tam VH, et al. J Antimicrob Chemother. 2002 Sep;50(3):425-8. doi: 10.1093/jac/dkf130. J Antimicrob Chemother. 2002. PMID: 12205070

3

Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.

Tam VH, McKinnon PS, Akins RL, Drusano GL, Rybak MJ. Tam VH, et al. Antimicrob Agents Chemother. 2003 Jun;47(6):1853-61. doi: 10.1128/AAC.47.6.1853-1861.2003. Antimicrob Agents Chemother. 2003. PMID: 12760858 Free PMC article.

4

Modelling time-kill studies to discern the pharmacodynamics of meropenem.

Tam VH, Schilling AN, Nikolaou M. Tam VH, et al. J Antimicrob Chemother. 2005 May;55(5):699-706. doi: 10.1093/jac/dki086. Epub 2005 Mar 16. J Antimicrob Chemother. 2005. PMID: 15772138

5

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

Tam VH, Schilling AN, Vo G, Kabbara S, Kwa AL, Wiederhold NP, Lewis RE. Tam VH, et al. Antimicrob Agents Chemother. 2005 Sep;49(9):3624-30. doi: 10.1128/AAC.49.9.3624-3630.2005. Antimicrob Agents Chemother. 2005. PMID: 16127031 Free PMC article.

6

Mathematical modelling of resistance emergence.

Tam VH, Nikolaou M. Tam VH, et al. J Antimicrob Chemother. 2005 Nov;56(5):983; author reply 983-4. doi: 10.1093/jac/dki341. Epub 2005 Sep 19. J Antimicrob Chemother. 2005. PMID: 16172104 No abstract available.

7

A new modeling approach to the effect of antimicrobial agents on heterogeneous microbial populations.

Nikolaou M, Tam VH. Nikolaou M, et al. Among authors: tam vh. J Math Biol. 2006 Feb;52(2):154-82. doi: 10.1007/s00285-005-0350-6. Epub 2005 Sep 29. J Math Biol. 2006. PMID: 16195922

8

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.

Tam VH, Schilling AN, Neshat S, Poole K, Melnick DA, Coyle EA. Tam VH, et al. Antimicrob Agents Chemother. 2005 Dec;49(12):4920-7. doi: 10.1128/AAC.49.12.4920-4927.2005. Antimicrob Agents Chemother. 2005. PMID: 16304153 Free PMC article.

9

Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.

Wiederhold NP, Tam VH, Chi J, Prince RA, Kontoyiannis DP, Lewis RE. Wiederhold NP, et al. Among authors: tam vh. Antimicrob Agents Chemother. 2006 Feb;50(2):469-73. doi: 10.1128/AAC.50.2.469-473.2006. Antimicrob Agents Chemother. 2006. PMID: 16436698 Free PMC article.

10

Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.

Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA. Tam VH, et al. Antimicrob Agents Chemother. 2006 Aug;50(8):2626-31. doi: 10.1128/AAC.01165-05. Antimicrob Agents Chemother. 2006. PMID: 16870751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page